+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

Mayus Kinase 3 (JAK3) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Mayus Kinase 3 (JAK3) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Cathepsin K/S Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Cathepsin K/S Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Cathepsin K Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Cathepsin K Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Protein Kinase C (PKC) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Protein Kinase C (PKC) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Polo-Like Kinase Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Polo-Like Kinase Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
IkappaB Kinase (IKK) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

IkappaB Kinase (IKK) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
cFMS Kinase Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

cFMS Kinase Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Cyclin-Dependent Kinase 2 (CDK2) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Cyclin-Dependent Kinase 2 (CDK2) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Focal Adhesion Kinase (FAK) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Focal Adhesion Kinase (FAK) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
HER2Negative Metastatic Breast Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

HER2Negative Metastatic Breast Cancer - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 180 Pages
  • Global
From
Advanced Breast Cancer In Premenopausal Women - Pipeline Insight, 2025 - Product Thumbnail Image

Advanced Breast Cancer In Premenopausal Women - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Mayus Kinase 1 (JAK1) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Mayus Kinase 1 (JAK1) Inhibitor - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 90 Pages
  • Global
From
Matrix Metalloproteinase 9 (MMP-9) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Matrix Metalloproteinase 9 (MMP-9) Inhibitor - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Neo Antigen T-cell Therapy - Pipeline Insight, 2025 - Product Thumbnail Image

Neo Antigen T-cell Therapy - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
T Cell Therapy - Pipeline Insight, 2025 - Product Thumbnail Image

T Cell Therapy - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Advanced Ovarian Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Advanced Ovarian Cancer - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 210 Pages
  • Global
From
ESR1-Mutated Metastatic Breast Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

ESR1-Mutated Metastatic Breast Cancer - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Breast Cancer- Pipeline Insight, 2025 - Product Thumbnail Image

Breast Cancer- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 180 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more